Cargando…
Lipidoid Nanoparticles for siRNA Delivery to the Intestinal Epithelium: In Vitro Investigations in a Caco-2 Model
Short interfering ribonucleic acid (siRNA) therapeutics show promise for the treatment of intestinal diseases by specifically suppressing the expression of disease relevant proteins. Recently, a class of lipid-like materials termed “lipidoids” have been shown to potently deliver siRNA to the liver a...
Autores principales: | Ball, Rebecca L., Knapp, Christopher M., Whitehead, Kathryn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508104/ https://www.ncbi.nlm.nih.gov/pubmed/26192592 http://dx.doi.org/10.1371/journal.pone.0133154 |
Ejemplares similares
-
Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells
por: Khare, Purva, et al.
Publicado: (2021) -
Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract
por: Ball, Rebecca L., et al.
Publicado: (2018) -
Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles
por: Lokras, Abhijeet, et al.
Publicado: (2021) -
Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design
por: de Groot, Anne Marit, et al.
Publicado: (2018) -
Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection
por: Ma, Feihe, et al.
Publicado: (2020)